Literature DB >> 14962306

Identification of the Kna/Knb polymorphism and a method for Knops genotyping.

J M Moulds1, B J Thomas, O Doumbo, D A Diallo, K E Lyke, C V Plowe, J A Rowe, D J Birmingham.   

Abstract

BACKGROUND: DNA mutations resulting in the McCoy and Swain-Langley polymorphisms have been identified on complement receptor 1 (CR1)-a ligand for rosetting of Plasmodium falciparum-infected RBCs. The molecular identification of the Kna/Knb polymorphism was sought to develop a genotyping method for use in the study of the Knops blood group and malaria. STUDY DESIGN AND METHODS: CR1 deletion constructs were used in inhibition studies of anti-Kna. PCR amplification of Exon 29 was followed by DNA sequencing. A PCR-RFLP was developed with NdeI, BsmI, and MfeI for the detection of Kna/Knb, McCa/McCb, and Sl1/Sl2, respectively. Knops phenotypes were determined with standard serologic techniques.
RESULTS: A total of 310 Malian persons were phenotyped for Kna with 200 (64%) Kn(a+) and 110 (36%) Kn(a-). Many of the Kn(a-) exhibited the Knops-null phenotype, that is, Helgeson. The Kna/b DNA polymorphism was identified as a V1561M mutation with allele frequencies of Kna (V1561) 0.9 and Knb (M1561) 0.1.
CONCLUSION: The high frequency (18%) of Knb in West African persons suggests that it is not solely a Caucasian trait. Furthermore, because of the high incidence of heterozygosity as well as amorphs, accurate Knops typing of donors of African descent is best accomplished by a combination of molecular and serologic techniques.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14962306      PMCID: PMC2877259          DOI: 10.1111/j.1537-2995.2004.00615.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  16 in total

1.  Knops-Helgeson (Kna), a high-frequency erythrocyte antigen.

Authors:  M Helgeson; J Swanson; H F Polesky
Journal:  Transfusion       Date:  1970 May-Jun       Impact factor: 3.157

2.  Decay accelerating activity of complement receptor type 1 (CD35). Two active sites are required for dissociating C5 convertases.

Authors:  M Krych-Goldberg; R E Hauhart; V B Subramanian; B M Yurcisin; D L Crimmins; D E Hourcade; J P Atkinson
Journal:  J Biol Chem       Date:  1999-10-29       Impact factor: 5.157

3.  The serology of the York-Cost-McCoy-Knops red blood cell system.

Authors:  L Molthan
Journal:  Am J Med Technol       Date:  1983-01

4.  The status of the Mccoy/Knops antigens.

Authors:  L Molthan
Journal:  Med Lab Sci       Date:  1983-01

5.  P. falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1.

Authors:  J A Rowe; J M Moulds; C I Newbold; L H Miller
Journal:  Nature       Date:  1997-07-17       Impact factor: 49.962

6.  Identification of complement receptor one (CR1) polymorphisms in west Africa.

Authors:  J M Moulds; L Kassambara; J J Middleton; M Baby; I Sagara; A Guindo; S Coulibaly; D Yalcouye; D A Diallo; L Miller; O Doumbo
Journal:  Genes Immun       Date:  2000-06       Impact factor: 2.676

7.  Neutralization of Knops system antibodies using soluble complement receptor 1.

Authors:  J M Moulds; K E Rowe
Journal:  Transfusion       Date:  1996-06       Impact factor: 3.157

8.  Serological investigation and clinical significance of high-titer, low-avidity (HTLA) antibodies.

Authors:  M K Moulds
Journal:  Am J Med Technol       Date:  1981-10

9.  Antiglobulin testing for CR1-related (Knops/McCoy/Swain-Langley/York) blood group antigens: negative and weak reactions are caused by variable expression of CR1.

Authors:  J M Moulds; J J Moulds; M Brown; J P Atkinson
Journal:  Vox Sang       Date:  1992       Impact factor: 2.144

10.  The C3b/C4b receptor is recognized by the Knops, McCoy, Swain-langley, and York blood group antisera.

Authors:  J M Moulds; M W Nickells; J J Moulds; M C Brown; J P Atkinson
Journal:  J Exp Med       Date:  1991-05-01       Impact factor: 14.307

View more
  14 in total

Review 1.  Development of complement therapeutics for inhibition of immune-mediated red cell destruction.

Authors:  Karina Yazdanbakhsh
Journal:  Transfusion       Date:  2005-08       Impact factor: 3.157

2.  Extensive genomic variability of knops blood group polymorphisms is associated with sickle cell disease in Africa.

Authors:  Kimberley C Duru; Jenelle A Noble; Aldiouma Guindo; Li Yi; Ikhide G Imumorin; Dapa A Diallo; Bolaji N Thomas
Journal:  Evol Bioinform Online       Date:  2015-03-09       Impact factor: 1.625

3.  Severity of malaria in relation to a complement receptor 1 polymorphism: a case-control study.

Authors:  Rebecca Tettey; Patrick Ayeh-Kumi; Prudence Tettey; George O Adjei; Richard H Asmah; Daniel Dodoo
Journal:  Pathog Glob Health       Date:  2015-04-27       Impact factor: 2.894

4.  Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting.

Authors:  J Alexandra Rowe; Ian G Handel; Mahamadou A Thera; Anne-Marie Deans; Kirsten E Lyke; Abdoulaye Koné; Dapa A Diallo; Ahmed Raza; Oscar Kai; Kevin Marsh; Christopher V Plowe; Ogobara K Doumbo; Joann M Moulds
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-24       Impact factor: 11.205

5.  Complement receptor 1 and the molecular pathogenesis of malaria.

Authors:  Monika Gandhi
Journal:  Indian J Hum Genet       Date:  2007-05

6.  Association between Knops blood group polymorphisms and susceptibility to malaria in an endemic area of the Brazilian Amazon.

Authors:  Aparecida Maria Fontes; Simone Kashima; Ricardo Bonfim-Silva; Rochele Azevedo; Kuruvilla Joseph Abraham; Sérgio Roberto Lopes Albuquerque; José Orlando Bordin; Dante Mário Langhi Júnior; Dimas Tadeu Covas
Journal:  Genet Mol Biol       Date:  2011-10-01       Impact factor: 1.771

7.  Complement receptor 1 polymorphisms associated with resistance to severe malaria in Kenya.

Authors:  Vandana Thathy; JoAnn M Moulds; Bernard Guyah; Walter Otieno; José A Stoute
Journal:  Malar J       Date:  2005-11-08       Impact factor: 2.979

8.  Human genetic polymorphisms in the Knops blood group are not associated with a protective advantage against Plasmodium falciparum malaria in Southern Ghana.

Authors:  Helle H Hansson; Jørgen A Kurtzhals; Bamenla Q Goka; Onike P Rodriques; Francis N Nkrumah; Thor G Theander; Ib Christian Bygbjerg; Michael Alifrangis
Journal:  Malar J       Date:  2013-11-07       Impact factor: 2.979

9.  Circulating Immune Complex Levels are Associated with Disease Severity and Seasonality in Children with Malaria from Mali.

Authors:  Bolaji N Thomas; Dapa A Diallo; Ghislain T Noumsi; Joann M Moulds
Journal:  Biomark Insights       Date:  2012-07-03

10.  Red blood cell complement receptor one level varies with Knops blood group, α(+)thalassaemia and age among Kenyan children.

Authors:  D H Opi; S Uyoga; E N Orori; T N Williams; J A Rowe
Journal:  Genes Immun       Date:  2016-02-04       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.